Menu
← Oncology Approval Tracker
FDA DECISION ·
Imkeldi
imatinib mesylate · Shorla Oncology
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Oral solution for specified imatinib indications, including Philadelphia chromosome-positive CML and ALL, PDGFR-rearranged MDS/MPD, selected systemic mastocytosis and eosinophilic disorders, dermatofibrosarcoma protuberans, and KIT-positive gastrointestinal stromal tumors. Age, prior treatment and biomarker requirements depend on the indication.
LAMPGEN ANALYSIS
Why it matters
A ready-to-administer liquid adds an option for patients who have difficulty taking tablets, including children in the applicable leukemia settings.
What research teams should watch
Use the concentration and oral syringe in dosing instructions, and reconcile milligrams and milliliters at every transition of care.
PRIMARY RECORDS